{"id":82927,"date":"2026-05-08T18:00:34","date_gmt":"2026-05-08T12:30:34","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=82927"},"modified":"2026-05-08T18:00:35","modified_gmt":"2026-05-08T12:30:35","slug":"astrazeneca-pharma-india-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/","title":{"rendered":"AstraZeneca Pharma India Share Price Target 2026: Expert Forecast, Growth Catalysts and Key Risks"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p>The <strong>AstraZeneca Pharma India share price target<\/strong> for 2026 stands at Rs 11200 as per the latest analyst forecast, implying 27 percent upside from the current market price of Rs 8800. Investors tracking the <strong>AstraZeneca Pharma India share price target 2026<\/strong> need to understand the full picture including growth catalysts, FY27 earnings timeline, key risks, and the bull vs bear case scenarios. This article covers every dimension of the <strong>AstraZeneca Pharma India share price target<\/strong> thesis updated April 2026.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here to Get Free Investment Predictions on Univest<\/strong><\/a><\/p>\n<p>Track live AstraZeneca Pharma India price, FII or DII flows and analyst targets on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#AstraZeneca_Pharma_India_Company_Overview\" title=\"AstraZeneca Pharma India Company Overview\">AstraZeneca Pharma India Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Why_Analysts_Set_the_AstraZeneca_Pharma_India_Share_Price_Target_at_Rs_11200_for_2026\" title=\"Why Analysts Set the AstraZeneca Pharma India Share Price Target at Rs 11200 for 2026\">Why Analysts Set the AstraZeneca Pharma India Share Price Target at Rs 11200 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#FY27_Earnings_Delivery_and_Revenue_Acceleration\" title=\"FY27 Earnings Delivery and Revenue Acceleration\">FY27 Earnings Delivery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Sustained_domestic_demand_from_rising_incomes\" title=\"Sustained domestic demand from rising incomes\">Sustained domestic demand from rising incomes<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Global_supply_chain_realignment_favouring_India\" title=\"Global supply chain realignment favouring India\">Global supply chain realignment favouring India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Union_Budget_2026-27_Policy_Support\" title=\"Union Budget 2026-27 Policy Support\">Union Budget 2026-27 Policy Support<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Bull_Case_Base_Case_and_Bear_Case_for_AstraZeneca_Pharma_India_Share_Price_Target\" title=\"Bull Case, Base Case and Bear Case for AstraZeneca Pharma India Share Price Target\">Bull Case, Base Case and Bear Case for AstraZeneca Pharma India Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Key_Risks_to_the_AstraZeneca_Pharma_India_Share_Price_Target\" title=\"Key Risks to the AstraZeneca Pharma India Share Price Target\">Key Risks to the AstraZeneca Pharma India Share Price Target<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Earnings_Miss_Risk\" title=\"Earnings Miss Risk\">Earnings Miss Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Macro_and_Global_Headwinds\" title=\"Macro and Global Headwinds\">Macro and Global Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Sector-Specific_Risks\" title=\"Sector-Specific Risks\">Sector-Specific Risks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#FII_Outflows\" title=\"FII Outflows\">FII Outflows<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#AstraZeneca_Pharma_India_Financial_Snapshot_FY25_to_FY27\" title=\"AstraZeneca Pharma India Financial Snapshot FY25 to FY27\">AstraZeneca Pharma India Financial Snapshot FY25 to FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Technical_Outlook_for_AstraZeneca_Pharma_India_Share_Price\" title=\"Technical Outlook for AstraZeneca Pharma India Share Price\">Technical Outlook for AstraZeneca Pharma India Share Price<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#What_is_the_AstraZeneca_Pharma_India_share_price_target_for_2026\" title=\"What is the AstraZeneca Pharma India share price target for 2026?\">What is the AstraZeneca Pharma India share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Is_AstraZeneca_Pharma_India_a_good_buy_at_Rs_8800\" title=\"Is AstraZeneca Pharma India a good buy at Rs 8800?\">Is AstraZeneca Pharma India a good buy at Rs 8800?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_AstraZeneca_Pharma_India\" title=\"What is the 52 week high and low of AstraZeneca Pharma India?\">What is the 52 week high and low of AstraZeneca Pharma India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#What_sector_does_AstraZeneca_Pharma_India_belong_to\" title=\"What sector does AstraZeneca Pharma India belong to?\">What sector does AstraZeneca Pharma India belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#What_is_the_bull_case_for_AstraZeneca_Pharma_India_share_price\" title=\"What is the bull case for AstraZeneca Pharma India share price?\">What is the bull case for AstraZeneca Pharma India share price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#What_are_the_key_risks_to_the_AstraZeneca_Pharma_India_share_price_target\" title=\"What are the key risks to the AstraZeneca Pharma India share price target?\">What are the key risks to the AstraZeneca Pharma India share price target?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/astrazeneca-pharma-india-share-price-target-2026\/#Recent_Article\" title=\"Recent Article\">Recent Article<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"AstraZeneca_Pharma_India_Company_Overview\"><\/span><strong>AstraZeneca Pharma India Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Tap to Access Best Research on Univest<\/strong><\/a><\/p>\n<p>AstraZeneca Pharma India (NSE: ASTRAZEN) is a listed company in India&#8217;s Pharma sector with a market capitalisation of Rs 18530 crore. At CMP Rs 8800 against a 52 week range of Rs 7400 to Rs 10200, the stock currently offers meaningful upside to the analyst price forecast of Rs 11200. For more share price target analysis, visit <a href=\"https:\/\/univest.in\/blogs\"><strong>Univest Blogs<\/strong><\/a>.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>ASTRAZEN<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharma<\/td>\n<\/tr>\n<tr>\n<td>CMP April 2026<\/td>\n<td>Rs 8800<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 10200<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 7400<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 18530 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>48x<\/td>\n<\/tr>\n<tr>\n<td>12M Analyst Price Forecast<\/td>\n<td>Rs 11200<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 13400<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 6720<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Why_Analysts_Set_the_AstraZeneca_Pharma_India_Share_Price_Target_at_Rs_11200_for_2026\"><\/span><strong>Why Analysts Set the AstraZeneca Pharma India Share Price Target at Rs 11200 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Delivery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Delivery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>FY27 is the key year where analysts expect AstraZeneca Pharma India to deliver meaningful PAT growth. This is the primary variable that bridges the gap between the current CMP of Rs 8800 and the <strong>AstraZeneca Pharma India share price target 2026<\/strong> of Rs 11200. Analysts project 15 to 20 percent PAT growth in FY27. Track Q4 results live on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sustained_domestic_demand_from_rising_incomes\"><\/span><strong>Sustained domestic demand from rising incomes<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained domestic demand from rising incomes is a key growth driver that analysts highlight in supporting the <strong>AstraZeneca Pharma India share price target<\/strong> of Rs 11200. The Pharma sector is expanding at 12 to 18 percent annually, and AstraZeneca Pharma India is well-positioned to capture a rising share. Discover top Pharma stocks on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Global_supply_chain_realignment_favouring_India\"><\/span><strong>Global supply chain realignment favouring India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Global supply chain realignment favouring India provides an additional lever that can help AstraZeneca Pharma India exceed analyst projections and potentially push the stock toward the bull case target of Rs 13400. Compare AstraZeneca Pharma India with sector peers on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s rate cut cycle that commenced in 2026 reduces AstraZeneca Pharma India&#8217;s borrowing costs and stimulates end-market demand, supporting the <strong>AstraZeneca Pharma India share price target 2026<\/strong> of Rs 11200.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Policy_Support\"><\/span><strong>Union Budget 2026-27 Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27 capex continuity and PLI scheme extensions create a constructive backdrop for AstraZeneca Pharma India&#8217;s Pharma business, directly supporting the <strong>AstraZeneca Pharma India share price target 2026<\/strong> bull case of Rs 13400.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_Base_Case_and_Bear_Case_for_AstraZeneca_Pharma_India_Share_Price_Target\"><\/span><strong>Bull Case, Base Case and Bear Case for AstraZeneca Pharma India Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Assumption<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 13400<\/td>\n<td>FY27 revenue growth exceeds 25 percent, margin expansion of 200 bps, sector re-rating<\/td>\n<\/tr>\n<tr>\n<td>Base Case Forecast<\/td>\n<td>Rs 11200<\/td>\n<td>FY27 revenue growth of 15 to 18 percent, stable margins, current P\/E sustained<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 6720<\/td>\n<td>Revenue growth disappoints below 10 percent, margin pressure, valuation de-rating<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For live tracking of AstraZeneca Pharma India analyst price targets and ratings, use the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_AstraZeneca_Pharma_India_Share_Price_Target\"><\/span><strong>Key Risks to the AstraZeneca Pharma India Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_Miss_Risk\"><\/span><strong>Earnings Miss Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>If AstraZeneca Pharma India reports quarterly earnings below expectations, the <strong>AstraZeneca Pharma India share price target<\/strong> will likely face downward revision. Watch Q4 FY26 results closely on <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Macro_and_Global_Headwinds\"><\/span><strong>Macro and Global Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The US 26 percent reciprocal tariff announcement of April 2026 has created global macro uncertainty that adds near-term risk to the <strong>AstraZeneca Pharma India share price target 2026<\/strong> timeline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector-Specific_Risks\"><\/span><strong>Sector-Specific Risks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Regulatory changes, input cost volatility, and competitive intensity in the Pharma space could pressure margins and delay realisation of the <strong>AstraZeneca Pharma India share price target<\/strong> of Rs 11200.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Outflows\"><\/span><strong>FII Outflows<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Continued FII selling in Indian equities could suppress the valuation multiples needed for AstraZeneca Pharma India to reach its analyst price forecast of Rs 11200 within the 12 month horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"AstraZeneca_Pharma_India_Financial_Snapshot_FY25_to_FY27\"><\/span><strong>AstraZeneca Pharma India Financial Snapshot FY25 to FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>FY25 Actual<\/th>\n<th>FY26 Estimate<\/th>\n<th>FY27 Estimate<\/th>\n<\/tr>\n<tr>\n<td>Revenue (Rs Cr)<\/td>\n<td>Refer NSE filing<\/td>\n<td>Refer NSE filing<\/td>\n<td>Refer NSE\/BSE filing<\/td>\n<\/tr>\n<tr>\n<td>EBITDA Margin<\/td>\n<td>Refer NSE filing<\/td>\n<td>Refer NSE filing<\/td>\n<td>Expected expansion<\/td>\n<\/tr>\n<tr>\n<td>PAT (Rs Cr)<\/td>\n<td>Refer NSE filing<\/td>\n<td>Refer NSE filing<\/td>\n<td>15 to 20 percent growth<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 18530 crore<\/td>\n<td>Higher at 52W peak<\/td>\n<td>Tracks price movement<\/td>\n<\/tr>\n<tr>\n<td>P\/E Ratio<\/td>\n<td>48x<\/td>\n<td>Current level<\/td>\n<td>Target implies re-rating<\/td>\n<\/tr>\n<tr>\n<td>52 Week High \/ Low<\/td>\n<td colspan=\"3\">Rs 10200 \/ Rs 7400<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>If you want to track AstraZeneca Pharma India financial metrics, analyst ratings and peer comparisons in real time, <a href=\"https:\/\/univest.in\/screeners\"><strong>check the Univest Screener for live data<\/strong><\/a>.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Outlook_for_AstraZeneca_Pharma_India_Share_Price\"><\/span><strong>Technical Outlook for AstraZeneca Pharma India Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>AstraZeneca Pharma India is trading at Rs 8800, currently attempting to build a base above its 52 week low of Rs 7400. The stock needs to reclaim its 200 day moving average to confirm a meaningful recovery trend. The <strong>AstraZeneca Pharma India share price target<\/strong> of Rs 11200 set by analysts assumes fundamental delivery over the next 12 months rather than near-term price action. Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track AstraZeneca Pharma India live price and set alerts.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>AstraZeneca Pharma India share price target 2026<\/strong> of Rs 11200 reflects analyst conviction on FY27 earnings delivery, structural sector tailwinds, and the favourable domestic macro environment. The bull case of Rs 13400 is achievable if the company executes above expectations. Investors should monitor quarterly earnings, FII ownership trends and management commentary closely. For real-time tracking and research, use the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<p><em>This article is for informational and educational purposes only and is not investment advice. Univest is SEBI registered (INH000013776). Please consult a SEBI registered financial advisor before making any investment decision.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_AstraZeneca_Pharma_India_share_price_target_for_2026\"><\/span><strong>What is the AstraZeneca Pharma India share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>AstraZeneca Pharma India share price target<\/strong> for 2026 is Rs 11200 as per the analyst price forecast, implying 27 percent upside from the current price of Rs 8800. The bull case target is Rs 13400 and the bear case is Rs 6720.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_AstraZeneca_Pharma_India_a_good_buy_at_Rs_8800\"><\/span><strong>Is AstraZeneca Pharma India a good buy at Rs 8800?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At Rs 8800, AstraZeneca Pharma India trades at a trailing P\/E of 48x and offers potential upside to the analyst price forecast of Rs 11200. Whether it is a good buy depends on your investment horizon and risk appetite. Always consult a SEBI registered financial advisor.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_AstraZeneca_Pharma_India\"><\/span><strong>What is the 52 week high and low of AstraZeneca Pharma India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 52 week high of AstraZeneca Pharma India is Rs 10200 and the 52 week low is Rs 7400. The current CMP of Rs 8800 positions the stock at a meaningful discount to its peak, which is factored into the analyst <strong>AstraZeneca Pharma India share price target 2026<\/strong>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_AstraZeneca_Pharma_India_belong_to\"><\/span><strong>What sector does AstraZeneca Pharma India belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>AstraZeneca Pharma India belongs to India&#8217;s Pharma sector and trades on NSE with the ticker ASTRAZEN. Track the entire Pharma sector on the <a href=\"https:\/\/univest.in\/screeners\"><strong>Univest Screener<\/strong><\/a>.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_bull_case_for_AstraZeneca_Pharma_India_share_price\"><\/span><strong>What is the bull case for AstraZeneca Pharma India share price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case for AstraZeneca Pharma India share price is Rs 13400, which assumes revenue growth exceeding 25 percent in FY27, margin expansion of 200 basis points, and a positive re-rating of the Pharma sector. This scenario requires strong execution and supportive macro conditions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_AstraZeneca_Pharma_India_share_price_target\"><\/span><strong>What are the key risks to the AstraZeneca Pharma India share price target?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Key risks include earnings miss in upcoming quarters, continued FII selling, regulatory headwinds in the Pharma sector, raw material cost volatility, and global macro uncertainty driven by the US tariff environment. These risks could push the stock toward the bear case of Rs 6720.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Recent_Article\"><\/span><strong>Recent Article<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/why-is-liberty-shoes-share-price-falling\">Why Is Liberty Shoes Share Price Falling: Key Reasons and Investor Analysis 2026<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/why-is-shemaroo-entertainment-share-price-falling\">Why Is Shemaroo Entertainment Share Price Falling: Key Reasons and Investor Analysis 2026<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/why-is-orchid-pharma-share-price-falling\">Why Is Orchid Pharma Share Price Falling: Key Reasons and Investor Analysis 2026<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/why-is-bajaj-holdings-and-investment-share-price-falling\">Why Is Bajaj Holdings and Investment Share Price Falling: Key Reasons and Investor Analysis 2026<\/a><\/p>\n<p class=\"text-xl font-bold font-Inter mb-4\"><a href=\"https:\/\/univest.in\/blogs\/why-is-prism-johnson-share-price-falling\">Why Is Prism Johnson Share Price Falling: Key Reasons and Investor Analysis 2026<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca Pharma India share price target 2026 is Rs 11200. Analyst forecast, bull case Rs 13400, bear case Rs 6720. Growth catalysts, risks and full analysis<\/p>\n","protected":false},"author":28,"featured_media":84120,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3972],"class_list":["post-82927","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-target"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778243438:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["80"],"rank_math_title":["AstraZeneca Pharma India Share Price Target 2026 Forecast"],"rank_math_description":["AstraZeneca Pharma India share price target 2026 is Rs 11200. Analyst forecast, bull case Rs 13400, bear case Rs 6720. Growth catalysts, risks and full analysis."],"rank_math_focus_keyword":["AstraZeneca Pharma India Share Price Target"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_wp_old_date":["2026-05-07"],"_thumbnail_id":["84120"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["10778"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/08180014\/AstraZeneca-Pharma-India-Share-Price-Target-2026.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/82927","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=82927"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/82927\/revisions"}],"predecessor-version":[{"id":84121,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/82927\/revisions\/84121"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/84120"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=82927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=82927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=82927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}